Search Results 111-120 of 18905 for Neoplasm
The purpose of this study is to evaluate the efficacy and safety of INCB054828 in subjects with myeloid/lymphoid neoplasms with fibroblast growth factor ...
The main categories of pancreatic cysts can be divided into two groups, nonneoplastic or neoplastic cysts. ... Pancreatic cystic neoplasms: Clinical ...
Patients with high-risk myeloproliferative neoplasms (systemic mastocytosis [SM], advanced symptomatic hypereosinoophic disorder [PED], myelofibrosis [MF], and ...
Learn about the diagnosis and treatment of this usually benign, slow-growing tumor that begins in peripheral nerve cells.
He R, Chen D. Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy. Blood.
Many factors can make normal cells appear atypical, including inflammation and infection. Even normal aging can make cells appear abnormal.
The purpose of this study is to determine a dose of LY2784544 that may be safely administered to participants with myeloproliferative neoplasms.
... Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence Scottsdale/Phoenix, AZ; Jacksonville, FL. This is a Phase ...
PHOENIX – Mayo Clinic researchers have found that azathioprine, a drug commonly used to treat autoimmune disease, may increase the risk of myeloid neoplasms ...
... neoplasms. He improves the classification and treatment outcomes for people with myeloid neoplasm mutations. Premyeloid research. Dr. Al-Kali has written ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.